Monitor pharmaceutical brand coverage, regulatory narratives, and competitor activity across all channels
Perceptica provides media monitoring and analysis for pharmaceutical brands in Southeast Europe. Our platform covers clinical, business, and consumer health media, with analyst reports that separate regulatory intelligence from brand performance and safety narratives.
Context
The pharmaceutical media landscape in Southeast Europe
Pharmaceutical brands in Southeast Europe operate across a media environment where clinical press, regulatory authority communications, and consumer health media each play a distinct role - and where coverage in any one segment can quickly affect the others.
Pharmaceutical media spans clinical, business, and consumer health channels - each reaching a different audience
Coverage flows across specialist clinical publications, business press covering approvals and market access, and consumer health media.
Each segment reaches a different audience and carries different weight.
A brand that performs well in clinical press may be framed very differently in consumer health media.
Regulatory authority decisions generate consistent secondary coverage that reshapes brand and category perception
Drug approval, reimbursement eligibility, and market authorisation decisions generate media coverage that frames the products involved, even when reporting is nominally about regulatory process.
Brands monitoring regulatory sources can anticipate these perception shifts before the narrative forms.
Drug safety and adverse event narratives require early detection
Safety-related coverage typically originates in specialist clinical channels before moving to consumer health media and mainstream press.
The gap between specialist appearance and mainstream amplification is often narrow.
Early detection gives communications and medical affairs teams time to respond while the narrative is still forming.
Challenges
Media challenges specific to pharmaceutical brands in Southeast Europe
In pharma, the most consequential coverage moments - regulatory decisions, safety events, and competitive launches - each have a narrow response window. Monitoring that is not structured for the pharmaceutical media environment often detects them too late.
Regulatory coverage requires a faster response than standard brand monitoring provides
Coverage of regulatory decisions reaches mainstream business and health media within hours of the initial announcement.
By the time a weekly report arrives, the narrative is already formed.
Pharmaceutical brands need monitoring that surfaces regulatory coverage to medical affairs, regulatory affairs, or communications as it appears.
Safety and adverse event coverage escalates quickly once it reaches mainstream media
A safety story that receives early, contextualised coverage is a manageable reputational event.
The same story without a coordinated brand response can establish a persistent negative association across an entire product range.
Early detection in specialist and clinical sources, before mainstream amplification, is the critical intervention point.
Consumer health media and clinical press present different narratives about the same products
Healthcare professionals and patients access information about the same products through largely separate media ecosystems.
These sources regularly present divergent narratives on efficacy, safety, and value.
Without monitoring both simultaneously, brands work with an incomplete picture of how their products are perceived.
Process
Pharmaceutical media monitoring aligned with your brand
Perceptica's pharmaceutical monitoring is configured around regulatory authority coverage, and the separation of safety intelligence from brand and competitor monitoring, with analyst reporting structured by internal audience and business function.
Configure monitoring for your product portfolio, ingredients, and competitive landscape
Saved searches are set up covering brand names, product names, active ingredients, therapeutic area topics, competitor products, and regulatory authority channels, configured for single-product or multi-brand portfolios from day one.
Access live coverage dashboards tracking brand, competitor, and regulatory coverage in real time
Your team has direct access to dashboards showing mention volume, sentiment trends, and source breakdowns across all monitored searches. Competitor product and pipeline coverage is tracked in parallel with your own brand coverage.
Monitor safety and regulatory coverage as dedicated, separated intelligence streams
Safety and regulatory coverage are tracked in dedicated searches, separate from general brand monitoring. This ensures each internal team (medical affairs, regulatory affairs, communications) receives the intelligence relevant to their function as coverage appears.
Apply enhanced monitoring intensity during regulatory decisions and product launch windows
Alert thresholds and reporting cadence are adjusted during reimbursement decisions, approval announcements, and product launches - pre-planned against your regulatory calendar, not activated reactively after coverage has already appeared.
Receive analyst reports structured by audience and business function
After each monitoring period, launch, or regulatory event, you receive structured analyst reports connecting coverage patterns to the specific decisions each team needs to make, formatted separately for medical affairs, regulatory affairs, communications, and commercial.
Deliverables
Deliverables for pharmaceutical communications, medical affairs, and regulatory teams
Each deliverable is designed to answer a specific question that pharmaceutical teams face across the regulatory calendar, competitive landscape, and safety environment.
Regulatory Coverage Monitor
Structured tracking of media coverage generated by regulatory authority decisions (approvals, reimbursement changes, pricing revisions), identifying narratives that affect your product category even when coverage is framed as system-level policy.
Drug Safety and Adverse Event Alert
Real-time detection of safety-related coverage and adverse event language involving your products, with immediate analyst alert and trajectory assessment across clinical, consumer health, and mainstream media.
Competitor Coverage and Pipeline Brief
Regular tracking of how competitor brands, products, and pipeline candidates are covered across clinical, business, and consumer health media, including approval narratives, reimbursement news, and comparative positioning.
Launch and Campaign Effectiveness Report
Post-launch analysis connecting your PR and communications activities to coverage outcomes, measuring volume, sentiment, and reach relative to competitor activity in the same window.
Consumer Health Media Digest
Regular synthesis of how your brand and products are covered in consumer-facing health media - health portals, patient communities, and lifestyle press - surfacing perception trends that don't appear in clinical or business press.
Pharmaceutical Brand Reputation Summary
Quarterly synthesis of brand perception trends across all source types and audiences, covering coverage volume, sentiment trajectory, key narrative themes, and competitive position relative to the prior period.
Engagement model
How to engage Perceptica for pharmaceutical media intelligence
Perceptica works with pharmaceutical brands across four engagement types - aligned to regulatory cycles, safety events, and the launch calendar.
Ad hoc
A defined, time-limited engagement, typically a competitive coverage audit, pre-launch media landscape assessment, or post-launch effectiveness review. Suitable for brands with a specific strategic question or those evaluating Perceptica before scaling to continuous monitoring.
Activated for a crisis or reputational event
Rapid-onboarding monitoring configured around an emerging or anticipated reputational risk, a safety incident, adverse event narrative gaining media traction, or a negative coverage development requiring a coordinated response. Includes daily analyst briefings and alert protocols for the duration of the risk window.
Monthly to annual reporting
Ongoing media intelligence on a monthly, quarterly, bi-annual, or annual cadence. Covers brand and product coverage tracking, regulatory authority monitoring, competitor intelligence, safety detection, and consumer health media analysis. The most common engagement structure for pharmaceutical communications and medical affairs teams.
Event-based
Monitoring is configured around a specific pharmaceutical moment - a product launch, a reimbursement decision, an approval announcement, or a major communications push. Includes pre-event competitor landscape assessment, in-event coverage tracking with alerts, and a post-event effectiveness report. Can be standalone or layered on top of an existing regular engagement.
See how your brand is covered across clinical sources and mainstream media
Book a demo and explore live coverage of your products and brand across Southeast European media.
Request a demo